Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Andre Konski
Affiliation
Chester County Hospital
ORCID
Career Start Year
1982
Papers
182
H Index
41
Expertise
CM4AI Collaborator
Sarah J Ratcliffe (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36494031
Pneumothorax Associated With Deep Inspiration Breath Holding During Radiation Therapy for Breast Cancer.
Pract Radiat Oncol
2023
37393743
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
Gynecol Oncol
2023
37150264
Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001.
Int J Radiat Oncol Biol Phys
2023
36549347
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
Int J Radiat Oncol Biol Phys
2023
35960897
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial.
J Clin Oncol
2022
33237451
Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.
Ann Surg Oncol
2021
34125352
Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.
Ann Surg Oncol
2021
32058845
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
J Clin Oncol
2020
31054745
ACR Appropriateness Criteria<sup>®</sup> Noninvasive Clinical Staging of Primary Lung Cancer.
J Am Coll Radiol
2019
31574418
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).
Eur J Cancer
2019
31445109
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer.
Int J Radiat Oncol Biol Phys
2019
29331574
A Medicare cost analysis of MRI- versus CT-based high-dose-rate brachytherapy of the cervix: Can MRI-based planning be less costly?
Brachytherapy
2018
30050797
Cost effectiveness of prostate cancer radiotherapy.
Transl Androl Urol
2018
30202809
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.
Adv Radiat Oncol
2018
30559923
An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy.
J Radiat Oncol
2018
27727066
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.
Int J Radiat Oncol Biol Phys
2017
28412775
Defining Value in Radiation Oncology: Approaches to Weighing Benefits vs Costs.
Oncology (Williston Park)
2017
28230650
ACR Appropriateness Criteria® Resectable Pancreatic Cancer.
Am J Clin Oncol
2017
29332448
Helical Therapy is Safe for Lung Stereotactic Body Radiation Therapy Despite Limitations in Achieving Sharp Dose Gradients.
Technol Cancer Res Treat
2017
28830662
Letting Patients Decide How to Receive Their Imaging Results; A Good Idea or a Dangerous Practice? Part 2: Counterpoint: Patients Should Not Have Unchaperoned Access to Radiology Reports.
J Am Coll Radiol
2017
28687830
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.
JAMA Oncol
2017
27729298
Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.
J Thorac Oncol
2017
27006359
Radiation Oncology Practice: Adjusting to a New Reimbursement Model.
J Oncol Pract
2016
26511494
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.
J Neurooncol
2016
26581671
Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.
Acta Oncol
2016
27422109
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer.
Oncology (Williston Park)
2016
25440267
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.
Ann Thorac Surg
2015
26371522
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer.
Am J Clin Oncol
2015
26281845
ACR Appropriateness Criteria® Resectable Stomach Cancer.
Oncology (Williston Park)
2015
24621427
Limitations of the bowel bag contouring technique in the definitive treatment of cervical cancer.
Pract Radiat Oncol
2014
25841508
Radiotherapy and radioembolization for liver metastases.
Ann Palliat Med
2014
25441058
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer.
Radiother Oncol
2014
25323613
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation.
Oncology (Williston Park)
2014
25349290
Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
J Clin Oncol
2014
24983373
Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer.
Br J Cancer
2014
25022451
Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.
Appl Health Econ Health Policy
2014
25154822
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.
J Clin Oncol
2014
24778402
Reply to M.J. Brenner et al and I.R. Vogelius et al.
J Clin Oncol
2014
24732058
Inadvertent high-dose therapy with temozolomide in a child with recurrent pontine glioma followed by a rapid clinical response but deteriorated after substitution with low-dose therapy.
J Pediatr Hematol Oncol
2014
24909911
Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway.
Radiat Res
2014
24558509
ACR Appropriateness Criteria®-Anal Cancer.
Gastrointest Cancer Res
2014
23167547
ACR Appropriateness Criteria ® spinal bone metastases.
J Palliat Med
2013
24674412
Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma.
Pract Radiat Oncol
2013
24077456
Radioprotection of lung tissue by soy isoflavones.
J Thorac Oncol
2013
24101042
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.
J Clin Oncol
2013
23870233
Gamma Knife radiosurgery in the management of brainstem metastases.
Clin Neurol Neurosurg
2013
23835374
Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMR.
J Appl Clin Med Phys
2013
24021346
Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.
Radiother Oncol
2013
23781699
Is hypofractionation the solution? The financial implications of breast cancer treatments.
Oncology (Williston Park)
2013
23519570
Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases.
Support Care Cancer
2013
1 - 50 of 182
Column Actions
Search
Recommended Authors
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
8
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year
2013
Number of shared co-authors
2
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year
2012
Number of shared co-authors
12
Christine Massey
Princess Margaret Cancer Centre
Career Start Year
2010
Number of shared co-authors
2
Bridget F Koontz
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
7
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
2006
Number of shared co-authors
9
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year
2005
Number of shared co-authors
4
Albert J Chang
University of California Los Angeles
Career Start Year
2003
Number of shared co-authors
8
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
2
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
7
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year
2001
Number of shared co-authors
3
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year
2001
Number of shared co-authors
5
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year
2001
Number of shared co-authors
9
Chandana A Reddy
Cleveland Clinic
Career Start Year
2000
Number of shared co-authors
6
Drew Moghanaki
University of California Los Angeles
Career Start Year
2000
Number of shared co-authors
7
Robert B Den
Thomas Jefferson University Hospital
Career Start Year
1999
Number of shared co-authors
10
Constantine A Mantz
University of Chicago
Career Start Year
1997
Number of shared co-authors
6
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year
1996
Number of shared co-authors
3
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year
1994
Number of shared co-authors
8
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
3
William L Barrett
Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA.
Career Start Year
1992
Number of shared co-authors
2
Philippe Lambin
Maastricht University
Career Start Year
1992
Number of shared co-authors
5
Thomas M Pisansky
Mayo Clinic
Career Start Year
1992
Number of shared co-authors
19
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year
1991
Number of shared co-authors
8
David Joseph
Sir Charles Gairdner Hospital
Career Start Year
1990
Number of shared co-authors
8
Anthony V D'Amico
Duke University Medical Center
Career Start Year
1988
Number of shared co-authors
11
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Career Start Year
1983
Number of shared co-authors
4
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
3
James W Denham
University of Newcastle
Career Start Year
1980
Number of shared co-authors
9
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year
1976
Number of shared co-authors
23
row(s) 1 - 30 of 30
Collaborators
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Co-authored papers
28
Alan Pollack
University of Miami Miller School of Medicine
Co-authored papers
12
Mark K Buyyounouski
Stanford University
Co-authored papers
10
William F Hartsell
Proton Therapy Center- Northwestern University
Co-authored papers
10
Mack Roach
University of California San Francisco
Co-authored papers
9
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers
8
Alexandra L Hanlon
Virginia Tech
Co-authored papers
8
Karyn A Goodman
Mount Sinai Hospital
Co-authored papers
8
Charles W Scarantino
University of North Carolina
Co-authored papers
7
Edward Chow
University of Toronto
Co-authored papers
6
Charles R Thomas
Oregon Health & Science University
Co-authored papers
6
Stephanie L Pugh
Co-authored papers
5
Al B Benson
Northwestern University Feinberg School of Medicine
Co-authored papers
5
William F Demas
Salem Regional Medical Center
Co-authored papers
5
Ivy A Petersen
Mayo Clinic
Co-authored papers
4
John H Suh
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers
4
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
Robert Ivker
Prostate Cancer Center of New Jersey.
Co-authored papers
4
Minesh P Mehta
Co-authored papers
4
Christopher U Jones
Sutter Medical Center Sacramento
Co-authored papers
4
Adel K El-Naggar
MD Anderson Cancer Center
Co-authored papers
3
David I Rosenthal
MD Anderson Cancer Center
Co-authored papers
3
Jennifer James
Institute on Health and Aging, University of California san francisco
Co-authored papers
3
Michael L Steinberg
University of California los angeles
Co-authored papers
3
Andrea M Barsevick
Thomas Jefferson University
Co-authored papers
2
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Jeffrey Greenspoon
Juravinski Cancer Centre
Co-authored papers
2
Amy Chang
Pamela Youde Nethersole Eastern Hospital
Co-authored papers
2
Sarah J Ratcliffe (CM4AI)
University of Virginia
Co-authored papers
2
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers
2
1 - 30